Replies

The enterovirus was brought to the U.S. by the current wave of illegal immigrants. The disease was almost nonexistent in the U.S. prior to recently when unscreened illegals were moved throughout the U.S. by the Obama Administration.

See my previous comment. Enterovirus D-68 was identified back in the 60s, and has rarely been seen anywhere prior to the current outbreak. Not here (though there have been smaller outbreaks), not in Central America, not anywhere.

There are none so blind as those who will not see.

So you are saying that the current outbreak of enterovirus at the exact same time and place as unscreened, untested, illegal immigrants being dispersed into the general population is just a big coincidence.

Oh my, how could that possibly have happened?

Alright, what is your explanation for the sudden outbreak of enterovirus, TB and other diseases at exactly the same time illegals were brought into the U.S.

Not here (though there have been smaller outbreaks), not in Central America, not anywhere.

You know better than to say that. I provided you with a link to a complete study in the Virology Journal. I will link it again. You completely brushed off the warnings contained in this study. Our government knew prior to trafficking effected children of the biological risks to the American population.

Human rhinoviruses and enteroviruses in influenza-like illness in Latin America

Read it again and take your "crisis messaging" elsewhere.

From the article:

Results
Our subjects had a median age of 3 years and a 1.2:1.0 male:female ratio. HRV was identified in 16% and HEV was identified in 3%. HRVs accounted for a higher frequency of isolates in those of younger age, in particular children < 1 years old. HRV-C accounted for 38% of all HRVs detected. Phylogenetic analysis revealed a high proportion of recombinant strains between HRV-A/HRV-C and between HEV-A/HEV-B. In addition, both EV-D68 and EV-A71 were identified.

Conclusions
In Latin America as in other regions, HRVs and HEVs account for a substantial proportion of respiratory viruses identified in young people with ILI, a finding that provides additional support for the development of pharmaceuticals and vaccines targeting these pathogens.